SC83288 is a clinical development candidate for the treatment of severe malaria. (Q37622611)
Jump to navigation
Jump to search
scientific article published on 31 January 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | SC83288 is a clinical development candidate for the treatment of severe malaria. |
scientific article published on 31 January 2017 |
Statements
SC83288 is a clinical development candidate for the treatment of severe malaria (English)
Stefano Pegoraro
Maëlle Duffey
Yulin Wang
Roman Rösemann
Roland Baumgartner
Stefanie K Fehler
Leonardo Lucantoni
Dominique Mazier
Henri J Vial
Stefan Strobl
Cecilia P Sanchez
31 January 2017
1 reference